Involvement of CD40-CD40L signaling in postischemic lung injury

被引:17
|
作者
Moore, TM [1 ]
Shirah, WB [1 ]
Khimenko, PL [1 ]
Paisley, P [1 ]
Lausch, RN [1 ]
Taylor, AE [1 ]
机构
[1] Univ S Alabama, Coll Med, Dept Physiol, Mobile, AL 36688 USA
关键词
inflammation; filtration coefficient; lymphocytes; macrophage inflammatory protein-2;
D O I
10.1152/ajplung.00016.2002
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Our studies show that ischemia-reperfusion (I/R) in the isolated rat lung causes retention of lymphocytes, which is associated with increased microvascular permeability, as determined by quantitative measurement of the microvascular filtration coefficient (K-f,K-c). Immunoneutralization of either CD40 or CD40L, cell surface proteins important in lymphocyte-endothelial cell proinflammatory events, results in significantly lower postischemic K-f,K-c values. Antagonism of CD40-CD40L signaling also results in attenuation of I/R-elicited macrophage inflammatory protein-2 production. Rat lymphocytes activated ex vivo with phorbol 12-myristate, 13-acetate increased K-f,K-c in isolated lungs independently of I/R, and this increase was prevented by pretreating lungs with anti-CD40. In addition to lymphocyte involvement via CD40-CD40L interactions, our studies also show that I/R injury is potentiated by antagonism of IL-10 produced locally within the postischemic lung, whereas exogenous, rat recombinant IL-10 provided protection against I/R-induced microvascular damage. Thus acute lymphocyte involvement in lung I/R injury involves CD40-CD40L signaling mechanisms, and these events may be influenced by local IL-10 generation.
引用
收藏
页码:L1255 / L1262
页数:8
相关论文
共 50 条
  • [21] CD40 signalling cascades induced by differential CD40-CD40L interaction
    Sarode, A.
    Saha, B.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 31 - 31
  • [22] Involvement of CD40-CD40L and ICOS-ICOSL in the development of chronic rhinosinusitis by targeting eosinophils
    Zhou, Aina
    Shi, Chenxi
    Fan, Yuhui
    Zheng, Yushuang
    Wang, Jue
    Liu, Zhichen
    Xie, Huanxia
    Liu, Jisheng
    Jiao, Qingqing
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [23] The CD40-CD40L Dyad as Immunotherapeutic Target in Cardiovascular Disease
    Bosmans, Laura A.
    Bosch, Lena
    Kusters, Pascal J. H.
    Lutgens, Esther
    Seijkens, Tom T. P.
    JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH, 2021, 14 (01) : 13 - 22
  • [24] Promises and obstacles for the blockade of CD40-CD40L interactions in allotransplantation
    Li, Xian-Liang
    Menoret, Severine
    Le Mauff, Brigitte
    Angin, Mathieu
    Anegon, Ignacio
    TRANSPLANTATION, 2008, 86 (01) : 10 - 15
  • [25] CD40-CD40L与缺血性脑卒中
    解学军
    赤峰学院学报(自然科学版), 2008, (自然科学版) : 76 - 79
  • [26] CD40-CD40L expression in lesional and unaffected skin of pemphigus
    Giomi, B
    Caproni, M
    Pestelli, E
    Volpi, W
    Fabbri, P
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2001, 117 (03) : 779 - 779
  • [27] CD40-CD40L interactions required for elimination of Cryptosporidium parvum
    Hayward, A
    Cosyns, M
    Jones, M
    Tsirkin, S
    Kikutani, H
    FASEB JOURNAL, 1998, 12 (05): : A922 - A922
  • [28] Impact of the CD40-CD40L Dyad in Alzheimer's Disease
    Giunta, Brian
    Rezai-Zadeh, Kavon
    Tan, Jun
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2010, 9 (02) : 149 - 155
  • [29] Fibroblast matrixmetalloproteinases are modulated by CD40-CD40L interactions.
    Blieden, TM
    Rhyu, IC
    Turner, CK
    Phipps, RP
    JOURNAL OF DENTAL RESEARCH, 2000, 79 : 626 - 626
  • [30] CD40-CD40L interaction in immunity against protozoan infections
    Chamekh, Mustapha
    JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY, 2007,